118 related articles for article (PubMed ID: 36123880)
1. ATRX status in patients with gliomas: Radiomics analysis.
Meng L; Zhang R; Fa L; Zhang L; Wang L; Shao G
Medicine (Baltimore); 2022 Sep; 101(37):e30189. PubMed ID: 36123880
[TBL] [Abstract][Full Text] [Related]
2. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
[TBL] [Abstract][Full Text] [Related]
3. Multicenter clinical radiomics-integrated model based on [
Zhang L; Pan H; Liu Z; Gao J; Xu X; Wang L; Wang J; Tang Y; Cao X; Kan Y; Wen Z; Chen J; Huang D; Chen S; Li Y
Eur Radiol; 2023 Feb; 33(2):872-883. PubMed ID: 35984514
[TBL] [Abstract][Full Text] [Related]
4. A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas.
Wu S; Zhang X; Rui W; Sheng Y; Yu Y; Zhang Y; Yao Z; Qiu T; Ren Y
Eur Radiol; 2022 May; 32(5):3187-3198. PubMed ID: 35133485
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Prediction of IDH1 Mutation and ATRX Expression Loss in Low-Grade Gliomas Using Multiparametric MR Radiomic Features.
Ren Y; Zhang X; Rui W; Pang H; Qiu T; Wang J; Xie Q; Jin T; Zhang H; Chen H; Zhang Y; Lu H; Yao Z; Zhang J; Feng X
J Magn Reson Imaging; 2019 Mar; 49(3):808-817. PubMed ID: 30194745
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi-institutional Study.
Shen N; Lv W; Li S; Liu D; Xie Y; Zhang J; Zhang J; Jiang J; Jiang R; Zhu W
J Magn Reson Imaging; 2023 Mar; 57(3):884-896. PubMed ID: 35929909
[TBL] [Abstract][Full Text] [Related]
7. Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging.
Lin K; Cidan W; Qi Y; Wang X
Med Phys; 2022 Jul; 49(7):4419-4429. PubMed ID: 35366379
[TBL] [Abstract][Full Text] [Related]
8. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
[TBL] [Abstract][Full Text] [Related]
10. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
12. Using radiomics based on multicenter magnetic resonance images to predict isocitrate dehydrogenase mutation status of gliomas.
Liu Y; Zheng Z; Wang Z; Qian X; Yao Z; Cheng C; Zhou Z; Gao F; Dai Y
Quant Imaging Med Surg; 2023 Apr; 13(4):2143-2155. PubMed ID: 37064376
[TBL] [Abstract][Full Text] [Related]
13. Application of Enhanced T1WI of MRI Radiomics in Glioma Grading.
Zhou H; Xu R; Mei H; Zhang L; Yu Q; Liu R; Fan B
Int J Clin Pract; 2022; 2022():3252574. PubMed ID: 35685548
[TBL] [Abstract][Full Text] [Related]
14. MRI features predict p53 status in lower-grade gliomas via a machine-learning approach.
Li Y; Qian Z; Xu K; Wang K; Fan X; Li S; Jiang T; Liu X; Wang Y
Neuroimage Clin; 2018; 17():306-311. PubMed ID: 29527478
[TBL] [Abstract][Full Text] [Related]
15. Radiomics Profiling Identifies the Incremental Value of MRI Features beyond Key Molecular Biomarkers for the Risk Stratification of High-Grade Gliomas.
Yang G; Sha Y; Wang X; Tan Y; Zhang H
Contrast Media Mol Imaging; 2022; 2022():8952357. PubMed ID: 35386727
[TBL] [Abstract][Full Text] [Related]
16. Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging.
Hashido T; Saito S; Ishida T
J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):606-613. PubMed ID: 34270479
[TBL] [Abstract][Full Text] [Related]
17. A radiomics model based on DCE-MRI and DWI may improve the prediction of estimating IDH1 mutation and angiogenesis in gliomas.
Wang J; Hu Y; Zhou X; Bao S; Chen Y; Ge M; Jia Z
Eur J Radiol; 2022 Feb; 147():110141. PubMed ID: 34995947
[TBL] [Abstract][Full Text] [Related]
18. A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas.
Lu J; Li X; Li H
Clin Radiol; 2022 Aug; 77(8):e560-e567. PubMed ID: 35595562
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics for Prediction of H3K27M Mutation in Midline Gliomas.
Kandemirli SG; Kocak B; Naganawa S; Ozturk K; Yip SSF; Chopra S; Rivetti L; Aldine AS; Jones K; Cayci Z; Moritani T; Sato TS
World Neurosurg; 2021 Jul; 151():e78-e85. PubMed ID: 33819703
[TBL] [Abstract][Full Text] [Related]
20. Radiomics analysis of multiparametric MRI for the preoperative evaluation of pathological grade in bladder cancer tumors.
Wang H; Hu D; Yao H; Chen M; Li S; Chen H; Luo J; Feng Y; Guo Y
Eur Radiol; 2019 Nov; 29(11):6182-6190. PubMed ID: 31016445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]